Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

被引：0
|
作者：
Couto, Maria Eduarda [1 ]
Borges, Marina [1 ]
Bento, Maria Jose [1 ]
Daniela, Rita Calisto Marta [1 ]
Magalhaes, Marques [1 ]
Ajmal, Adil
Niklas, Nicolas [2 ]
Dushkin, Kirill [2 ]
MacDougall, Finaly [2 ]
Wolf, Andrea [3 ]
mShabid, Shabana [3 ]
vonMetzler, Ivana [4 ]
机构：
[1] Portuguese Oncol Inst Porto, Porto, Portugal
[2] IQVIA Ltd, London, England
[3] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr, Frankfurt, Germany
[4] Goethe Univ, Univ Hosp Frankfurt, Dept Med, Hematol Oncol, Frankfurt, Germany
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5012
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [31] REAL-WORLD TREATMENT PATTERNS AND PATIENTS CHARACTERISTICS IN MULTIPLE MYELOMA ACROSS EUROPE
    Fernandez, A.
    Zomas, A.
    Papakostas, E.
    Do, T.
    Russo, M.
    D'Ambrosio, R.
    Schneidewind, G.
    HAEMATOLOGICA, 2017, 102 : 517 - 518
  • [32] Treatment patterns, outcomes, and physician decision-making in multiple myeloma: A real-world European study
    Ribbands, A.
    Perera, S.
    D'Estrube, T.
    Bailey, A. L.
    Luke, E.
    Wang, P. Feng
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S836 - S836
  • [33] Real-World Treatment Patterns and Outcomes of Daratumumab Retreatment in Multiple Myeloma in the United States
    Girvan, Allicia
    Yu, Junhua
    Emechebe, Nnadozie
    Kamalakar, Rajesh
    Luo, Yan
    BLOOD, 2022, 140 : 5266 - 5267
  • [34] Real-World Multiple Myeloma Treatment Patterns By Patient Characteristics and Outcomes in the United States
    Richter, Joshua
    Singh, Erin
    Rice, Megan S.
    BLOOD, 2021, 138
  • [35] Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
    Lecat, Catherine S. Y.
    Taube, Jessica B. B.
    Wilson, William
    Carmichael, Jonathan
    Parrish, Christopher
    Wallis, Gabriel
    Kyriakou, Charalampia
    Lee, Lydia
    Mahmood, Shameem
    Papanikolaou, Xenofon
    Rabin, Neil K. K.
    Sive, Jonathan
    Wechalekar, Ashutosh D. D.
    Yong, Kwee
    Cook, Gordon
    Popat, Rakesh
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Real-World Treatment Patterns from the HUMANS Study in Multiple Myeloma in Denmark
    Abildgaard, Niels
    Waage, Anders
    Hansson, Markus
    Anttila, Pekka
    Szilcz, Mate
    Ma, Yuanjun
    Rubin, Katrine Hass
    von Arx, Lill-Brith
    Orstavik, Sigurd
    Bent-Ennakhil, Nawal
    Freilich, Jonatan
    Gavini, Francois
    Green, Anders
    BLOOD, 2019, 134
  • [37] Real-World Retrospective Study of 46 Patients with Macrofocal Multiple Myeloma (MFMM)
    Yan, Wenqiang
    Fan, Huishou
    Xu, Jingyu
    Liu, Jiahui
    Du, Chenxing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Qiu, Lugui
    An, Gang
    BLOOD, 2021, 138 : 3765 - +
  • [38] Bortezomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma patients: a real-world study of China
    Xu, Jingyu
    Yan, Wenqiang
    Fan, Huishou
    Liu, Jiahui
    Du, Chenxing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Qiu, Lugui
    An, Gang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S159 - S159
  • [39] Treatment Patterns and Clinical Outcomes in High-Risk Multiple Myeloma Patients Carrying the 17p Deletion: A Multi-Center Retrospective Observational Study
    Cohen, Yael
    Gatt, Moshe E.
    Lavi, Noa
    Ganzel, Chezi
    Magen, Hila
    Avivi, Irit
    Tadmor, Tamar
    Suriu, Celia
    Dolberg, Osnat Jarchowsky
    Papushado, Amitai
    Trestman, Svetlana
    Ram, Ron
    BLOOD, 2016, 128 (22)
  • [40] Lenalidomide and Low-dose Dexamethasone for Treatment of Relapsed/Refractory Multiple Myeloma: Real-world Treatment Patterns from the PREAMBLE Study
    Goldschmidt, Hartmut
    Cook, Gordon
    Kuter, David
    Vij, Ravi
    Popov, Sergey
    Zyczynski, Teresa
    Davis, Catherine
    Durie, Brian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E126 - E127
12345